The  Mandrax MQL Test 25 is a rapid, qualitative urine drug screening test designed specifically to detect the presence of Mandrax (methaqualone), a sedative-hypnotic drug. Methaqualone, commonly known as Mandrax, is a powerful central nervous system depressant that was once widely prescribed for insomnia and anxiety but is now largely controlled due to its high potential for abuse. The test is typically used in workplaces, rehabilitation programs, and law enforcement settings to screen for the use of this drug.

The MQL Test 25 is a 25-test pack, making it a cost-effective solution for bulk screening or repeated testing. The test is easy to use and provides fast results, usually within minutes, which helps to identify recent Mandrax use. It works by detecting specific metabolites of methaqualone in the urine, providing a clear indication of whether the drug is present above a certain threshold.

This test is highly accurate and is designed for use in non-clinical settings, offering a convenient and reliable method for monitoring individuals for Mandrax consumption. However, any positive results should be followed by confirmatory testing, such as Gas Chromatography-Mass Spectrometry (GC-MS), to validate the findings. The Mandrax MQL Test 25 ensures a quick and efficient screening process to maintain safety and compliance in various environments.